122 related articles for article (PubMed ID: 18328193)
21. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma].
Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL
Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267
[TBL] [Abstract][Full Text] [Related]
22. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
Mao C; Liu H; Chen P; Ye J; Teng L; Jia Z; Cao J
Oncotarget; 2015 Mar; 6(8):5707-19. PubMed ID: 25691059
[TBL] [Abstract][Full Text] [Related]
23. Recombinant adenovirus infection suppresses hTERT expression through virus-associated RNA-mediated induction of type 1 interferon.
Lee CH; Kim HW; Kim T; Lee SW
Biochem Biophys Res Commun; 2015 Mar; 458(4):830-5. PubMed ID: 25689720
[TBL] [Abstract][Full Text] [Related]
24. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter.
Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J
Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164
[TBL] [Abstract][Full Text] [Related]
25. Construction of a targeting adenoviral vector carrying AFP promoter for expressing EGFP gene in AFP-producing hepatocarcinoma cell.
Shi YJ; Gong JP; Liu CA; Li XH; Mei Y; Mi C; Huo YY
World J Gastroenterol; 2004 Jan; 10(2):186-9. PubMed ID: 14716819
[TBL] [Abstract][Full Text] [Related]
26. [Synergic effect of adenoviral vector-encoding human alpha-fetoprotein and interferon-gamma on immunity against hepatocellular carcinoma in mice].
Tan XH; Zhu Q
Ai Zheng; 2008 Feb; 27(2):155-9. PubMed ID: 18279612
[TBL] [Abstract][Full Text] [Related]
27. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
[TBL] [Abstract][Full Text] [Related]
28. [Gene therapy using a dominant negative form of the protein phosphatase 2A catalytic subunit a driven by a hepatoma tissue-specific promoter achieves effective growth inhibition of hepatoma cells].
Li DM; Li W; Tao M; Chen K; Gong FR; Xu ZK; Chen Z
Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):459-63. PubMed ID: 24034849
[TBL] [Abstract][Full Text] [Related]
29. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.
Kanai F; Lan KH; Shiratori Y; Tanaka T; Ohashi M; Okudaira T; Yoshida Y; Wakimoto H; Hamada H; Nakabayashi H; Tamaoki T; Omata M
Cancer Res; 1997 Feb; 57(3):461-5. PubMed ID: 9012474
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
[TBL] [Abstract][Full Text] [Related]
31. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
Cheng J; Leng X; Peng J
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
[TBL] [Abstract][Full Text] [Related]
32. [Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas].
Tan XH; Zhu Q; Liu C; Liu XL; Shao XT; Wei B
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):13-6. PubMed ID: 16737612
[TBL] [Abstract][Full Text] [Related]
33. Specific cellular immunity and antitumor responses in C57BL/6 mice induced by DNA vaccine encoding murine AFP.
Tian G; Yi JL; Xiong P
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):440-3. PubMed ID: 15313685
[TBL] [Abstract][Full Text] [Related]
34. Potent anti-hepatoma efficacy of HCCS1 via dual tumor-targeting gene-virotherapy strategy.
Zhang J; Gan Y; Gu J; Hu J; Liu X; Zhao X
Oncol Rep; 2008 Nov; 20(5):1035-40. PubMed ID: 18949398
[TBL] [Abstract][Full Text] [Related]
35. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
Biochem Biophys Res Commun; 2001 Oct; 287(4):1034-40. PubMed ID: 11573968
[TBL] [Abstract][Full Text] [Related]
36. Radioiodine gene therapy of hepatocellular carcinoma targeted human alpha fetoprotein.
Jin YN; Chung HK; Kang JH; Lee YJ; Kimm KI; Kim YJ; Kim S; Chung JK
Cancer Biother Radiopharm; 2008 Oct; 23(5):551-60. PubMed ID: 18986218
[TBL] [Abstract][Full Text] [Related]
37. Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma.
Lu SY; Sui YF; Li ZS; Pan CE; Ye J; Wang WY
World J Gastroenterol; 2003 Apr; 9(4):688-91. PubMed ID: 12679911
[TBL] [Abstract][Full Text] [Related]
38. Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma.
Zhang KJ; Qian J; Wang SB; Yang Y
J Biomed Sci; 2012 Feb; 19(1):20. PubMed ID: 22321574
[TBL] [Abstract][Full Text] [Related]
39. A hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas.
Kwon OJ; Kim PH; Huyn S; Wu L; Kim M; Yun CO
Clin Cancer Res; 2010 Dec; 16(24):6071-82. PubMed ID: 21169258
[TBL] [Abstract][Full Text] [Related]
40. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.
Bui LA; Butterfield LH; Kim JY; Ribas A; Seu P; Lau R; Glaspy JA; McBride WH; Economou JS
Hum Gene Ther; 1997 Dec; 8(18):2173-82. PubMed ID: 9449371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
